A Randomized Phase 3b/4 Study to Evaluate Concomitant Use of Topical Ivermectin 1% Cream and Doxycycline 40 Mg Modified-Release Capsules Versus Topical Ivermectin 1% Cream and Placebo in the Treatment of Severe Rosacea
Journal of the American Academy of Dermatology - United States
doi 10.1016/j.jaad.2019.05.063
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2020
Authors
Publisher
Elsevier BV